BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34535177)

  • 1. Enhanced disease progression due to persistent HPV-16/58 infections in Korean women: a systematic review and the Korea HPV cohort study.
    Seong J; Ryou S; Lee J; Yoo M; Hur S; Choi BS;
    Virol J; 2021 Sep; 18(1):188. PubMed ID: 34535177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
    Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
    J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program.
    Rosário A; Sousa A; Marinho-Dias J; Medeiros R; Lobo C; Leça L; Coimbra N; Tavares F; Baldaque I; Martins G; Monteiro P; Henrique R; Sousa H
    J Med Virol; 2023 Jan; 95(1):e28414. PubMed ID: 36541747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden and genotype distribution of high-risk Human Papillomavirus infection and cervical cytology abnormalities at selected obstetrics and gynecology clinics of Addis Ababa, Ethiopia.
    Ali KE; Mohammed IA; Difabachew MN; Demeke DS; Haile T; Ten Hove RJ; Kumssa TH; Woldu ZL; Haile EL; Tullu KD
    BMC Cancer; 2019 Aug; 19(1):768. PubMed ID: 31382907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
    Učakar V; Poljak M; Oštrbenk A; Klavs I
    J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of type-specific human papillomavirus prevalence in Iranian women with normal cytology, precancerous cervical lesions and invasive cervical cancer: Implications for screening and vaccination.
    Jalilvand S; Shoja Z; Nourijelyani K; Tohidi HR; Hamkar R
    J Med Virol; 2015 Feb; 87(2):287-95. PubMed ID: 25156655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study.
    Jensen KE; Thomsen LT; Schmiedel S; Frederiksen K; Norrild B; van den Brule A; Iftner T; Kjær SK
    Sex Transm Infect; 2014 Nov; 90(7):550-5. PubMed ID: 24728044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion.
    Plummer M; Schiffman M; Castle PE; Maucort-Boulch D; Wheeler CM;
    J Infect Dis; 2007 Jun; 195(11):1582-9. PubMed ID: 17471427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of HPV vaccination among HPV-infected women aged 20-60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study.
    Seong J; Ryou S; Yoo M; Lee J; Kim K; Jee Y; Cho CH; Kim SM; Hong SR; Jeong DH; Lee WC; Park JS; Kim TJ; Kee MK
    J Gynecol Oncol; 2020 Jan; 31(1):e4. PubMed ID: 31788994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology.
    Beyazit F; Sılan F; Gencer M; Aydin B; Paksoy B; Unsal MA; Ozdemir O
    Ginekol Pol; 2018; 89(2):62-67. PubMed ID: 29512809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent papillomavirus type-31 and type-45 infections predict the progression to squamous intraepithelial lesion.
    Schettino MT; Ammaturo FP; Grimaldi E; Legnante A; Marcello A; Donnarumma G; Colacurci N; Torella M
    Taiwan J Obstet Gynecol; 2014 Dec; 53(4):494-7. PubMed ID: 25510690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-16/18 high-risk HPV infection predicts disease persistence and progression in women with an initial interpretation of LSIL.
    Lyons YA; Kamat AA; Zhou H; Mody DR; Schwartz MR; Hobday C; Ge Y
    Cancer Cytopathol; 2015 Jul; 123(7):435-42. PubMed ID: 25903015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
    Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
    J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.
    Syrjänen K; Shabalova I; Naud P; Kozachenko V; Derchain S; Zakharchenko S; Roteli-Martins C; Nerovjna R; Longatto-Filho A; Kljukina L; Tatti S; Branovskaja M; Hammes LS; Branca M; Grunjberga V; Erzen M; Sarian LO; Juschenko A; Costa S; Podistov J; Syrjänen S;
    Int J Gynecol Cancer; 2009 Jul; 19(5):934-42. PubMed ID: 19574788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of human papillomavirus genotypes in Paraguayan women according to the severity of the cervical lesion.
    Mendoza LP; Arbiza J; Paez M; Kasamatsu E; Castro A; Giménez G; Basiletti J; Gonzalez J; Mongelós P; Picconi MA
    J Med Virol; 2011 Aug; 83(8):1351-7. PubMed ID: 21618554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Human Papillomavirus Genotyping before and after Cervical Conization for Squamous Intraepithelial Lesion.
    Iida Y; Sato S; Okawa M; Hikino K; Komatsu H; Kudoh A; Chikumi J; Oishi T; Harada T; Taniguchi F
    Acta Cytol; 2023; 67(1):17-26. PubMed ID: 36310011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis.
    Ogembo RK; Gona PN; Seymour AJ; Park HS; Bain PA; Maranda L; Ogembo JG
    PLoS One; 2015; 10(4):e0122488. PubMed ID: 25875167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological study of HPV infection in 40,693 women in Putian: a population study based on screening for high-risk HPV infection.
    Chen Z; Lin H; Zheng J; Cai L; Chen Z; Li J; Yu L
    BMC Infect Dis; 2022 Nov; 22(1):893. PubMed ID: 36443703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.